Department of Bacteriology, National Institute of Infectious Diseases, Tokyo, Japan.
Antimicrob Agents Chemother. 2011 Feb;55(2):623-30. doi: 10.1128/AAC.01215-10. Epub 2010 Nov 22.
Salmonella enterica serovar Typhimurium is frequently associated with life-threatening systemic infections, and the recent global emergence of multidrug resistance in S. enterica isolates from agricultural and clinical settings has raised concerns. In this study, we determined the whole-genome sequence of fluoroquinolone-resistant S. enterica serovar Typhimurium T000240 strain (DT12) isolated from human gastroenteritis in 2000. Comparative genome analysis revealed that T000240 displays high sequence similarity to strain LT2, which was originally isolated in 1940, indicating that progeny of LT2 might be reemerging. T000240 possesses a unique 82-kb genomic island, designated as GI-DT12, which is composed of multidrug resistance determinants, including a Tn2670-like composite transposon (class 1 integron [intI1, bla(oxa-30), aadA1, qacEΔ1, and sul1], mercury resistance proteins, and chloramphenicol acetyltransferase), a Tn10-like tetracycline resistance protein (tetA), the aerobactin iron-acquisition siderophore system (lutA and lucABC), and an iron transporter (sitABCD). Since GI-DT12 is flanked by IS1 derivatives, IS1-mediated recombination likely played a role in the acquisition of this genomic island through horizontal gene transfer. The aminoglycoside-(3)-N-acetyltransferase (aac(3)) gene and a class 1 integron harboring the dfrA1 gene cassette responsible for gentamicin and trimethoprim resistance, respectively, were identified on plasmid pSTMDT12_L and appeared to have been acquired through homologous recombination with IS26. This study represents the first characterization of the unique genomic island GI-DT12 that appears to be associated with possible IS1-mediated recombination in S. enterica serovar Typhimurium. It is expected that future whole-genome studies will aid in the characterization of the horizontal gene transfer events for the emerging S. enterica serovar Typhimurium strains.
鼠伤寒沙门氏菌血清型 Typhimurium 常与危及生命的全身感染有关,而最近在农业和临床环境中分离的沙门氏菌分离株中出现的多药耐药性引起了人们的关注。在这项研究中,我们确定了 2000 年从人类肠胃炎中分离出的氟喹诺酮耐药鼠伤寒沙门氏菌血清型 Typhimurium T000240 菌株的全基因组序列。比较基因组分析显示,T000240 与最初于 1940 年分离的 LT2 菌株具有高度的序列相似性,表明 LT2 的后代可能再次出现。T000240 拥有一个独特的 82kb 基因组岛,命名为 GI-DT12,由多种耐药决定因素组成,包括 Tn2670 样复合转座子(类 1 整合子 [intI1、bla(oxa-30)、aadA1、qacEΔ1 和 sul1]、汞抗性蛋白和氯霉素乙酰转移酶)、Tn10 样四环素耐药蛋白(tetA)、aerobactin 铁摄取铁载体系统(lutA 和 lucABC)和铁转运蛋白(sitABCD)。由于 GI-DT12 被 IS1 衍生物侧翼包围,因此 IS1 介导的重组可能通过水平基因转移在获得这个基因组岛中发挥了作用。氨基糖苷-(3)-N-乙酰转移酶(aac(3))基因和一个携带负责庆大霉素和甲氧苄啶耐药的 dfrA1 基因盒的类 1 整合子在质粒 pSTMDT12_L 上被鉴定出来,似乎是通过与 IS26 的同源重组获得的。本研究首次对与鼠伤寒沙门氏菌血清型 Typhimurium 中可能的 IS1 介导的重组相关的独特基因组岛 GI-DT12 进行了特征描述。预计未来的全基因组研究将有助于表征新兴的鼠伤寒沙门氏菌血清型 Typhimurium 菌株的水平基因转移事件。